Biofrontera Inc.BFRIEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BFRI Q3 2025 Key Financial Metrics
Revenue
$7.0M
Gross Profit
N/A
Operating Profit
$-6.3M
Net Profit
$-6.6M
Gross Margin
N/A
Operating Margin
-89.8%
Net Margin
-95.1%
YoY Growth
-22.5%
EPS
$-0.62
Financial Flow
Biofrontera Inc. Q3 2025 Financial Summary
Biofrontera Inc. reported revenue of $7.0M for Q3 2025, with a net profit of $-6.6M (-95.1% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $7.0M |
|---|---|
| Net Profit | $-6.6M |
| Gross Margin | N/A |
| Operating Margin | -89.8% |
| Report Period | Q3 2025 |
Biofrontera Inc. Annual Revenue by Year
Biofrontera Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $37.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $37.3M |
| 2023 | $34.1M |
| 2022 | $28.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.6M | $7.9M | $7.8M | $9.0M | $12.6M | $8.6M | $9.0M | $7.0M |
| YoY Growth | 4.4% | -9.4% | 34.0% | 1.3% | 18.5% | 8.5% | 15.2% | -22.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $27.9M | $24.6M | $21.6M | $18.5M | $22.1M | $16.6M | $20.1M | $15.4M |
| Liabilities | $23.1M | $26.4M | $10.7M | $13.0M | $17.7M | $16.1M | $24.8M | $18.0M |
| Equity | $4.8M | $-5.4M | $10.9M | $5.5M | $4.4M | $469000 | $-4.7M | $-2.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-8.9M | $-3.3M | $-4.7M | $-1.2M | $-1.0M | $-4.1M | $-3.0M | $-3.8M |